Senescence-associated β-galactosidase staining
Materials Required
Principle
Senescence-associated β-galactosidase staining detects β-galactosidase activity that is histochemically visible at pH 6.0 in senescent cells, where X-gal cleavage produces an insoluble blue precipitate observable by bright-field microscopy[1][4][5]. This activity reflects increased lysosomal β-galactosidase/lysosomal mass rather than a senescence-essential enzyme, because GLB1 depletion or genetic lysosomal β-galactosidase deficiency can abolish SA-β-gal staining while cells still undergo senescence[2][3]. SA-β-gal was originally reported in senescent but not presenescent fibroblasts and keratinocytes, absent from quiescent fibroblasts and terminally differentiated keratinocytes, and increased with donor age in human skin samples[1]. Because SA-β-gal can also appear in some non-senescent or tissue-specific contexts, interpretation should be paired with experimental controls and, when possible, independent senescence markers[7][8].
MCE has not independently verified the accuracy of these methods. They are for reference only.
Experimental Materials
• Fixative containing formaldehyde and glutaraldehyde is used to preserve cells before histochemical SA-β-gal staining[4][5].
• Citric acid/sodium phosphate buffer adjusted to pH 6.0 provides the assay pH at which senescence-associated β-galactosidase activity is detected[1][4][5].
• Potassium ferricyanide and potassium ferrocyanide are components of the X-gal staining solution used in published cytochemical SA-β-gal protocols[4][5].
• Sodium chloride and magnesium chloride are components of the published X-gal staining solution for SA-β-gal detection[4][5].
• Methanol was included in the Nature Protocols cytochemical protocol as a post-staining rinse before air-drying dishes[4].
• X-gal is the chromogenic β-galactosidase substrate used for histochemical SA-β-gal staining; cleavage generates the blue precipitate scored as SA-β-gal positivity[1][4][5].
• C12FDG is a fluorescent β-galactosidase substrate reported for fluorescence-based SA-β-gal detection by flow cytometry or microscopy, but the present protocol focuses on the X-gal histochemical method[4][7].
• A 37 °C incubator or chamber is used for X-gal staining incubation, and bright-field or phase-contrast microscopy is used to identify blue SA-β-gal-positive cells[4][5].
Experimental Procedure
• Prepare fresh X-gal staining solution containing 1 mg/mL X-gal, citric acid/sodium phosphate buffer at pH 6.0, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide, 150 mM NaCl, and 2 mM MgCl2[4][5].
• Use presenescent/young cells as negative controls and senescent cells generated by replicative aging or validated senescence induction as positive controls, because the original assay distinguished senescent from presenescent and quiescent cells[1][4][5].
• Wash samples with PBS, fix cells with formaldehyde/glutaraldehyde fixative, remove fixative, and wash again with PBS before adding X-gal staining solution[4][5].
• Add enough X-gal staining solution to cover the sample, incubate at 37 °C, and monitor development of blue staining; Debacq-Chainiaux et al. reported that blue color can appear within 2 h but is maximal after 12-16 h[4].
• After staining, wash samples with PBS; in the Nature Protocols dish-based cytochemical protocol, samples are washed twice with PBS for about 30 s, rinsed once with methanol, air-dried, and examined by bright-field or phase-contrast microscopy[4].
• Score SA-β-gal-positive cells as cells with blue cytoplasmic staining and report the percentage of positive cells among the counted population, because the assay identifies individual stained cells in culture and tissue preparations[1][4][5][6].
• Interpret SA-β-gal positivity as supportive but not stand-alone evidence of senescence, because cytochemical and fluorescence SA-β-gal methods can report different biological aspects in human peritoneal mesothelial cells and SA-β-gal activity in neurons may not uniquely indicate senescence[7][8].
Troubleshooting
Problem: Weak or delayed blue staining.
• Possible Cause: The staining reaction may not have reached maximal development.• Literature-supported Solution: Continue incubation within the published observation window, because blue color can be detectable within 2 h but maximal after 12-16 h[4].
Problem: No SA-β-gal staining despite other evidence of senescence.
• Possible Cause: SA-β-gal activity depends on lysosomal β-galactosidase encoded by GLB1, and GLB1-deficient or GLB1-depleted cells can undergo senescence without detectable SA-β-gal activity.• Literature-supported Solution: Do not exclude senescence based only on absent SA-β-gal staining; verify senescence using independent markers or assays[3].
Problem: Apparent SA-β-gal positivity in tissue or cell contexts where senescence status is uncertain.
• Possible Cause: SA-β-gal can reflect lysosomal β-galactosidase activity and may not uniquely indicate senescence in all tissues or cell types.• Literature-supported Solution: Interpret staining with matched controls and complementary senescence markers, especially in neurons or tissue sections[2][3][7][8].
Problem: Differences between cytochemical SA-β-gal positivity and quantitative fluorescence-based β-galactosidase activity.
• Possible Cause: In human peritoneal mesothelial cells, cytochemical and fluorescence SA-β-gal methods were reported to provide complementary but not identical information about replication-driven and time-associated aging.• Literature-supported Solution: Keep the analysis method consistent within an experiment and avoid directly equating cytochemical percentage-positive results with fluorescence enzyme-activity readouts[7].
References:
- [1]. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92(20):9363-9367. [Content Brief]
- [2]. Kurz DJ, et al. Senescence-associated beta-galactosidase reflects an increase in lysosomal mass during replicative ageing of human endothelial cells. J Cell Sci. 2000;113(Pt 20):3613-3622. [Content Brief]
- [3]. Lee BY, Han JA, Im JS, Morrone A, Johung K, Goodwin EC, et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell. 2006;5(2):187-195. [Content Brief]
- [4]. Debacq-Chainiaux F, et al. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc. 2009;4(12):1798-1806. [Content Brief]
- [5]. Itahana K, et al. Colorimetric detection of senescence-associated β galactosidase. Methods Mol Biol. 2013;965:143-156. [Content Brief]
- [6]. Itahana K, et al. Methods to detect biomarkers of cellular senescence: the senescence-associated beta-galactosidase assay. Methods Mol Biol. 2007;371:21-31. [Content Brief]
- [7]. Sosińska P, et al. Specificity of cytochemical and fluorescence methods of senescence-associated beta-galactosidase detection for ageing driven by replication and time. Biogerontology. 2014;15(4):407-413. [Content Brief]
- [8]. Piechota M, Sunderland P, Wysocka A, Nalberczak M, Sliwinska MA, Radwanska K, et al. Is senescence-associated β-galactosidase a marker of neuronal senescence? Oncotarget. 2016;7(49):81099-81109. [Content Brief]